Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01366417Phase 4Completed
Phase 4 trial of chlorhexidine + alcohol (2 arms), sponsored by BD. Primary endpoint: Antimicrobial Efficacy. Started May 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01366417.